# Enhancing Pharmaceutical Quality Standards: A Boost to India’s Global Standing

- Link: https://www.thailand-business-news.com/health/164761-enhancing-pharmaceutical-quality-standards-a-boost-to-indias-global-standing
- Published: 2024-10-04T08:24:00+07:00
- Author: News Desk

**India-based drugmakers must enhance manufacturing standards to address quality
concerns impacting pharmaceutical exports. Amid rising scrutiny, the government 
is incentivizing upgrades to improve compliance and maintain global dominance in
generics.**

**Key View**

ADVERTISEMENT

 * India-based drugmakers will need to invest in improving manufacturing standards
   to meet rising pressures on drug quality to protect pharmaceutical exports. 
 * India will continue to be a dominant force in global generic drug manufacturing
   and remain the primary supplier of generics in the US, but the industry continues
   to face scrutiny over quality control issues which will impact the approval rate
   of new drugs. 
 * Rising cost-containment measures across key developed markets, such as the US
   and the EU, will create new prospects for India-based generic drug manufacturers.

**India-based drugmakers will need to invest in improving manufacturing standards
to meet rising pressures on drug quality to protect pharmaceutical exports.** On
September 20 2024, India’s Department of Pharmaceuticals (DoP) announced it will
double the financial incentive for drug manufacturers to upgrade their manufacturing
facilities to INR20.0mn (USD0.2mn). The announcement follows a series of drug toxicity
cases surrounding medicines manufactured in India, resulting in fatalities in North
America, Africa and Central Asia, thereby raising serious concerns around India’s
pharmaceutical exports. In 2023, the US FDA conducted more than 200 inspections 
in India, representing a significant increase following a lull in unannounced inspections
during the Covid-19 pandemic. In January 2023, the Ministry of Health and Family
Welfare issued the revised Schedule M, which outlines the Good Manufacturing Practices(
GMP) and updated requirements concerning premises, plants and equipment for pharmaceutical
products, aiming to elevate the quality standards of India-based drugmakers. In 
February 2024, the US FDA announced it will increase inspections of India’s drug
manufacturing units amid growing concerns over the quality of drugs. 

The Indian pharmaceutical industry has long been a global leader in generic drug
manufacturing. However, recent concerns over quality standards have prompted the
Indian government to prioritize raising pharmaceutical quality benchmarks. By implementing
stricter regulations and ensuring adherence to international standards, India aims
to enhance the reputation of its pharmaceutical sector on the global stage.

### Related**Posts**

###  󠀁[TAT highlights “Healing is the New Luxury” at the Tourism Expo Japan 2026](https://www.thailand-business-news.com/health/331124-tat-highlights-healing-is-the-new-luxury-at-the-tourism-expo-japan-2026)󠁿

###  󠀁[Thailand’s Healthcare Expansion Strategy](https://www.thailand-business-news.com/health/327785-thailands-healthcare-expansion-strategy)󠁿

###  󠀁[Thailand unveils new strategy to attract higher-value global investment](https://www.thailand-business-news.com/markets/commodities/326892-thailand-unveils-new-strategy-to-attract-higher-value-global-investment)󠁿

###  󠀁[Apple’s Strategic iPhone Manufacturing Shift From China to India](https://www.thailand-business-news.com/india/322474-apples-strategic-iphone-manufacturing-shift-from-china-to-india)󠁿

Improving quality standards not only addresses safety concerns but also increases
the competitiveness of Indian pharmaceutical companies. As countries tighten regulations
around drug imports, India stands to benefit significantly from consistent high-
quality products. This change will likely lead to increased investments from international
pharmaceutical companies and greater access to global markets, strengthening India’s
position as a vital player in the global pharmaceutical supply chain.

Moreover, enhanced quality standards will contribute to public health both domestically
and internationally. By fostering trust in India’s pharmaceutical products, the 
government can help improve accessibility to essential medicines worldwide, ultimately
supporting the country’s soft power and reinforcing its status as a responsible 
global health partner.
[Read More](https://www.fitchsolutions.com/bmi/pharmaceuticals/government-focus-raising-pharmaceutical-quality-standards-will-improve-indias-external-positioning-24-09-2024)